Multiple Sclerosis

ZEPOSIA® (ozanimod), a Sphingosine 1-Phosphate Receptor Modulator for Relapsing Forms of Multiple Sclerosis

April 8th 2022, 7:16pm

Active Video Games Improve Balance Better Than Conventional Rehab in MS

January 7th 2022, 9:40pm

Video games that involve physical exertion was found to be more effective at improving balance in patients with multiple sclerosis (MS) compared with more conventional rehabilitation methods, investigators concluded.

Review Outlines Effective Diets, Exercise Techniques to Improve MS-Related Outcomes

January 5th 2022, 4:30pm

A review of published literature revealed which diet methods and forms of physical activity are most effective at improving patient-reported outcomes in patients with multiple sclerosis (MS).

Top 5 Most-Read Multiple Sclerosis Articles of 2021

December 30th 2021, 3:00pm

The top 5 most-read multiple sclerosis articles of 2021 focused on artificial intelligence, sunlight exposure, and COVID-19 risk factors, responses, and guidance for people with multiple sclerosis.

COVID-19 Vaccination May Provide Less Protection for Patients Taking Ocrelizumab, Fingolimod for MS

December 23rd 2021, 2:45pm

After administration of a COVID-19 vaccine, patients with multiple sclerosis (MS) taking ocrelizumab (Ocrevus) or fingolimod (Gilenya) may find themselves less protected against COVID-19 than the general population.

Racial Differences Detected Regarding Impact of Obesity on Retinal Integrity in MS

December 22nd 2021, 1:52pm

Obesity was found to have a significant association with retinal structure abnormalities related to multiple sclerosis (MS); however, the impact may be greater for African Americans than Caucasian Americans.

Coping Strategies Can Improve Quality of Life, Physical Disability in People With MS

December 16th 2021, 8:30pm

Coping strategies can play a role in influencing the health-related quality of life and physical disability of people with multiple sclerosis (MS), researchers concluded.

Study: 3 Types of COVID-19 Vaccines Deemed Safe for Use in Patients With MS

December 14th 2021, 9:41pm

Researchers recommend vaccination against COVID-19 for patients with multiple sclerosis (MS) after confirming that several types of vaccines are safe and produced no significant adverse events.

Smoking, Most DMTs Not Associated With Severe COVID-19 in Patients With MS

December 11th 2021, 9:00pm

Although obesity, diabetes, and certain comorbidities were all detected as risk factors for severe COVID-19 among people with multiple sclerosis (MS), other long-suspected risk factors, such as smoking and use of most disease-modifying therapies (DMTs), were not.

Lifestyle Interventions May Be Needed to Improve MS Management, Quality of Life

December 10th 2021, 6:30pm

Changes to diet, wellness, and physical activity could have a profound effect on patients’ ability to manage their multiple sclerosis (MS) and significantly improve their quality of life at the same time, researchers concluded.